Pelvic Neuro-Angiogenesis in Deep Endometriosis
Launched by ULUDAG UNIVERSITY · Feb 22, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how deep endometriosis affects nerve and blood vessel growth in the pelvic area. Endometriosis is a condition that affects many women, causing tissue similar to the lining of the uterus to grow outside of its normal place, which can lead to pain and other symptoms. The researchers want to find out how changes in the tissue around endometriotic nodules—specifically the nerve and blood vessel density—can contribute to pain and discomfort. This information may help doctors decide how much tissue needs to be removed during surgery to effectively relieve symptoms.
Women aged 18 to 45 who have been diagnosed with deep endometriosis, haven't found relief with medication, and are planning to undergo a specific type of surgery (called laparoscopic conservative endometriosis surgery) may be eligible to participate. During the trial, participants will have tissue samples taken during their surgery to study the nerve and blood vessel structures. This research aims to improve surgical outcomes and better understand how endometriosis affects women's health, even in areas that may look healthy at first glance.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Patients with suspicion of deep endometriosis (Physical Examination and MRI)
- • Patients with ineffective response to medical therapy
- • Patients who undergo laparoscopic conservative endometriosis surgery (douglasectomy)
- Exclusion Criteria:
- • Patients with malignity suspicion
- • Patients with extensive surgery (hysterectomy, ovariectomy)
- • Patients with previous endometriosis or another pelvic surgery
- • Patients with oocyte pick up procedure history
- • Patients with pelvic inflammatory disease history
About Uludag University
Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bursa, Gorukle, Turkey
Patients applied
Trial Officials
Gurkan Uncu, Prof.
Study Chair
Uludag University Faculty of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported